Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Hampshire Health Report.
Press releases published on May 2, 2025
Ocugen to Host Conference Call on Friday, May 9 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2025 Financial Results
GlobeNewswire
·
May 2, 2025
MALVERN, Pa., May 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss …
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
GlobeNewswire
·
May 2, 2025
LEIDEN, Netherlands …
Pacira BioSciences to Present New Data on Clinical Immunogenicity of Intra-Articular PCRX-201 and Its Implications for Dosing Strategy in Knee Osteoarthritis
GlobeNewswire
·
May 2, 2025
BRISBANE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced an upcoming podium …
Vaxart to Host First Quarter 2025 Business Update and Financial Results Conference Call on May 13
GlobeNewswire
·
May 2, 2025
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced it will provide a business update and report financial results for the first quarter ended March 31, 2025, …
ARS Pharmaceuticals Announces Co-Promotion Agreement with Partner and Global Allergy Leader ALK-Abelló A/S to Expand Reach of neffy® (epinephrine nasal spray) to Additional U.S. Pediatricians
GlobeNewswire
·
May 2, 2025
Agreement builds on landmark licensing deal between ARS Pharma and ALK-Abelló A/S, which provided ARS Pharma with $145 million upfront and ALK with commercialization rights to neffy in Canada, United Kingdom, European Union and certain other countries …
Cartesian Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
·
May 2, 2025
FREDERICK, Md., May 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapy for the treatment of autoimmune diseases, today announced the granting of …
What People Think About Prime Biome – Reviews & Complaints (CONSUMER REPORT)
GlobeNewswire
·
May 2, 2025
DEMOPOLIS, Alabama, May 02, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a meticulously curated skin health supplement created under doctor supervision and based on research-backed principles. The formulation uses a different approach in dealing with skin …
The Ensign Group Adds Skilled Nursing Facility in Washington
GlobeNewswire
·
May 2, 2025
SAN JUAN CAPISTRANO, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …
Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 2, 2025
Clinical trial of KH658 evaluates single suprachoroidal space administration of gene-therapy treatment for wet AMD CHENGDU, China and ROCKAWAY, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Chengdu Origen Biotechnology Co., Ltd. (“Chengdu Origen”) and Vanotech …
Orion Corporation: Managers’ transactions – Veli-Matti Mattila
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Veli-Matti Mattila Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Veli-Matti Mattila Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Hilpi Rautelin
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Hilpi Rautelin Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Hilpi Rautelin Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Kari Jussi Aho
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Kari Jussi Aho Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Maziar Mike Doustdar Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Ari Lehtoranta
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Ari Lehtoranta Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Corporation: Managers’ transactions – Eija Ronkainen
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Eija Ronkainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …
Orion Oyj: Johtohenkilöiden liiketoimet – Henrik Stenqvist
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Henrik Stenqvist Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Oyj: Johtohenkilöiden liiketoimet – Eija Ronkainen
GlobeNewswire
·
May 2, 2025
ORION OYJ JOHTOHENKILÖIDEN LIIKETOIMET 2.5.2025 KLO 11.45 Orion Oyj: Johtohenkilöiden liiketoimet – Eija Ronkainen Orion Oyj on saanut seuraavan Markkinoiden väärinkäyttöasetuksen (EU) N:o 596/2014 mukaisen ilmoituksen …
Orion Corporation: Managers’ transactions – Henrik Stenqvist
GlobeNewswire
·
May 2, 2025
ORION CORPORATION MANAGERS’ TRANSACTIONS 2 MAY 2025 at 11.45 EEST Orion Corporation: Managers’ transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding …